As the race to develop a Covid-19 vaccine accelerates, Inovio Pharmaceuticals (INO) filed a lawsuit claiming it is being held “hostage” by its long-standing contract manufacturer, which is refusing to provide crucial data needed to scale up vaccine production.

In arguing its case, Inovio maintained that a supply agreement requires VGXI to transfer technology know-how to other contract manufacturers if it declines to make a vaccine for Inovio. And recently, VGXI told Inovio that it cannot manufacture further batches of its experimental Covid-19 vaccine this year because it lacks manufacturing capacity, according to the lawsuit, filed in a Pennsylvania state court.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • During a pandemic and with co-operation among many biotechs it is immoral to withhold manufacturing information. Whether they have a breakthrough vaccine or not, please let me know how you would suggest we might put pressure on VGXI for this deplorable action? Thanks

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy